-+ 0.00%
-+ 0.00%
-+ 0.00%

Sangamo loses Nasdaq listing appeal after minimum bid price breach

PUBT·07/20/2026 20:44:59
Listen to the news
Sangamo loses Nasdaq listing appeal after minimum bid price breach
  • Sangamo received a Nasdaq Hearings Panel decision on July 14, 2026 denying its request to remain listed on Nasdaq Capital Market.
  • Nasdaq moved to delist the stock for failing the $1 minimum bid price rule; trading was suspended on May 5, 2026.
  • Shares now trade on the OTCID Basic Market as SGMOQ following the Chapter 11 filing on June 23, 2026.
  • Sangamo does not plan to seek further review; Nasdaq is expected to file Form 25 to delist and deregister the stock.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sangamo Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-309012), on July 20, 2026, and is solely responsible for the information contained therein.